Holdings
Venrock Adviser, LLC
As of Jun 30, 2026, Venrock Adviser, LLC reported 32 positions worth US$3.26B. Largest: Apogee Therapeutics, Inc., Oruka Therapeutics, Inc. and Erasca, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Apogee Therapeutics, Inc. | 8.49M | US$1.13B | no change | Jun 30, 2026 |
| Oruka Therapeutics, Inc. | 4.15M | US$395M | no change | Jun 30, 2026 |
| Erasca, Inc. | 17.9M | US$328M | +1.51M | Jun 30, 2026 |
| Spyre Therapeutics, Inc. | 2.99M | US$265M | −700K | Jun 30, 2026 |
| Dianthus Therapeutics, Inc. | 1.18M | US$115M | no change | Jun 30, 2026 |
| Ocular Therapeutix, Inc. | 10.3M | US$102M | no change | Jun 30, 2026 |
| Damora Therapeutics, Inc. | 3.6M | US$93.7M | no change | Jun 30, 2026 |
| Savara, Inc. | 14.7M | US$90.8M | +1.01M | Jun 30, 2026 |
| Jade Biosciences, Inc. | 3.22M | US$71.6M | no change | Jun 30, 2026 |
| Cogent Biosciences, Inc. | 1.64M | US$63.6M | −358K | Jun 30, 2026 |